Agenovir develops and commercializes a novel class of nuclease-based anti-viral therapeutics for diseases associated with viral reservoirs... Read more
Agenovir develops and commercializes a novel class of nuclease-based anti-viral therapeutics for diseases associated with viral reservoirs... Read more
News
May 09, 2018
BioCentury
Agenovir Corporation: Vir acquires antiviral gene-editing biotech Agenovir
Nov 01, 2017
PRWeb
Press Release: Agenovir Corporation : KBioBox Announces That Agenovir Corp Selected KBioBox's Custom Gene Edit Design Tool and Secondary Analysis.
Dec 06, 2016
ceomoves
Agenovir Corporation: Agenovir Corporation [SOUTH SAN FRANCISCO, Calif.] announced that it appointed Dirk Thye, as chief executive officer and a member of the board of directors.
May 18, 2016
BioCentury
Agenovir Corporation: Antiviral company Agenovir raises $10.6M
May 17, 2016
BioPortfolio
Agenovir Corporation: Agenovir Gets $10.6M To Take on Viral Infections With CRISPR
Agenovir Corporation Competitors
1
2
3
4
5
6
7
8
9
10